BOLD Stock Summary and Trading Ideas (Boundless Bio | NASDAQ:BOLD)

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Boundless Bio trades on the NASDAQ stock market under the symbol BOLD.

As of April 19, 2024, BOLD stock price declined to $10.09 with 157,364 million shares trading.

BOLD has a market cap of $224.39 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that BOLD belongs to (by Net Assets): VTI, VXF, VTWO, VTWG, VTWV.

BOLD support price is $10.71 and resistance is $11.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BOLD stock will trade within this expected range on the day.